Evidence map›Paper›PMID 25486475›Full record

ArticleCell cycle (Georgetown, Tex.)2014

BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.

Shu Wu, Yuanlong Ge, Laiqiang Huang, Haiying Liu, Yong Xue, Yong Zhao

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Melatonin alleviates alcoholic liver diseaseActa pharmaceutica Sinica. B · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Epigenetics of Aging and Aging-Associated Diseases.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Epigenetic regulation in cell senescence.Journal of molecular medicine (Berlin, Germany) · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Shu Wua The School of Life Sciences ; Tsinghua University ; Beijing , PR China.
Yuanlong Ge
Laiqiang Huang
Haiying Liu
Yong Xue
Yong Zhao
Centre for High Performance Computing · ZAMinistry of Education of the People's Republic of China · CNSun Yat-sen University · CNTsinghua University · CNUniversity of California System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomerase is often upregulated during initiation and/or progression of human tumors, suggesting that repression of telomerase might inhibit cancer growth or progression. Here, we report that BRG1, the ATPase subunit of the SWI/SNF chromatin remodeling complex, is a general suppressor of hTERT transcription in human cancer cells. While overexpression of BRG1 inhibits hTERT transcription, depletion of BRG1 stimulates transcription of hTERT, leading to higher telomerase activity and longer telomeres. Chromatin-immunoprecipitation assays revealed that BRG1 binds to the transcription start site (TSS) of the hTERT promoter and forms a ternary complex with histone deacetylase 2 (HDAC2). BRG1 remodels chromatin structure to facilitate the action of HDAC2, leading to deacetylation of H3K9ac and H4ac at the TSS and suppression of hTERT transcription. On the other hand, β-catenin binds to the TSS and stimulates hTERT transcription. Thus, BRG1/HDAC2 and β-catenin constitute a manipulative apparatus at the TSS to play opposite but complementary roles in regulating hTERT expression. These results uncover a yin-yang mechanism in modulating hTERT transcription and provide explanation for limited transcription of hTERT in human cancer cells. BRG1/HDAC2 may have a potential as an anti-cancer therapeutic and/or for reactivating cellular proliferative capacity in the context of in vitro tissue engineering.

Indexed as

Chromatin Assembly and DisassemblyGene Expression Regulation, NeoplasticAcetylationAdenosine Triphosphatasesbeta CateninCell Line, TumorDNA HelicasesGene Knockdown TechniquesHistone Deacetylase 2HistonesHumansLysineModels, BiologicalNuclear ProteinsPromoter Regions, GeneticProtein BindingAdenosine Triphosphatasesbeta CateninDNA HelicasesHDAC2 protein, humanHistone Deacetylase 2HistonesLysineNuclear ProteinsProtein SubunitsRNA, MessengerSMARCA4 protein, humanTelomeraseTranscription FactorsBRG1chromatin remodelingHDACsHDACs, histone deacetylaseSWI/SNF, SWItch/Sucrose NonFermentabletelomerasetelomeresTSA, Trichostatin ATSS, transcription start siteβ-catenin

Identifiers

PMID25486475
PMCPMC4612678
OpenAlexW2020425287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.